| Company name: |
STELLA PHARMA CORPORATION |
| Founded: |
June 1, 2007 |
| Head office: |
ORIX Kouraibashi Building, 3-2-7 Kouraibashi, Chuo-ku, Osaka 541-0043 |
| Type of business: |
Research, development, manufacturing and distribution of pharmaceuticals |
| Capital: |
3 billion yen |
| Board members |
|
|
| President & COO |
Koki Uehara |
| Director |
Kazumitsu Yabu |
| Director |
Toshimitsu Hayashi |
| Director |
Takahiro Kido |
| Outside Director (Audit and Supervisory Committee) |
Masaya Onishi |
| Outside Director (Audit and Supervisory Committee) |
Kohei Tsujii |
| Outside Director (Audit and Supervisory Committee) |
Yoshiyuki Fukuchi |
|
| Number of Employees: |
45 (as of March 2022) |
| Laboratory: |
Sakai R&D Center (Naka-ku, Sakai, Osaka) |
| Office: |
Tokyo branch (Chuo-ku, Tokyo) |
